Lessons Learned from CDC’s Strengthening U.S. Response to Resistant Gonorrhea

EpiLab epidemiologist John Pfister co-authored two papers published in the December 2021 supplement issue of Sexually Transmitted Diseases (Volume 48 – 12S):

Enhancing Gonococcal Antimicrobial Resistance Surveillance in Cisgender Women, Strengthening the US Response to Resistant Gonorrhea, 2018 to 2019
Wendel, Karen A.; Mauk, Kerry; Amsterdam, Lori; McNeil, Candice J.; Pfister, John R.; Mobley, Victoria; Mettenbrink, Christie; Nishiyama, Masayo; Terrell, Erica; Baldwin, Tamara; Pham, Cau D.; Nash, Evelyn E.; Kirkcaldy, Robert D.; Schlanger, Karen Less
Sexually Transmitted Diseases. 48(12S):S104-S110, December 2021.

Targeting Culture Criteria to Maximize Culture Positivity of Neisseria gonorrhoeae in 3 Sexual Health Clinic Settings
Nguyen, Trang Quyen; Jamison, Kelly; Pfister, John; Sankaran, Madeline; Amsterdam, Lori; Siemetzk-Kapoor, Ulrike; Pathela, Preeti Less
Sexually Transmitted Diseases. 48(12S):S144-S150, December 2021.

About John Pfister

Founder and Director, EpiLab Consulting
This entry was posted in Uncategorized. Bookmark the permalink.